Andrew S deLemos1, Marwan Ghabril2, Don C Rockey3, Jiezhun Gu4, Huiman X Barnhart4, Robert J Fontana5, David E Kleiner6, Herbert L Bonkovsky7. 1. Department of Medicine, Carolinas Medical Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC, 28204, USA. Andrew.deLemos@carolinashealthcare.org. 2. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. 3. Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. 4. Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. 5. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA. 6. Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA. 7. Department of Medicine, Wake Forest Baptist Medical Center, Winston Salem, NC, USA.
Abstract
BACKGROUND AND AIMS: Amoxicillin-clavulanate (AC) is the most frequent cause of idiosyncratic drug-induced injury (DILI) in the US DILI Network (DILIN) registry. Here, we examined a large cohort of AC-DILI cases and compared features of AC-DILI to those of other drugs. METHODS: Subjects with suspected DILI were enrolled prospectively, and cases were adjudicated as previously described. Clinical variables and outcomes of patients with AC-DILI were compared to the overall DILIN cohort and to DILI caused by other antimicrobials. RESULTS: One hundred and seventeen subjects with AC-DILI were identified from the cohort (n = 1038) representing 11 % of all cases and 24 % of those due to antimicrobial agents (n = 479). Those with AC-DILI were older (60 vs. 48 years, P < 0.001). AC-DILI was more frequent in men than women (62 vs. 39 %) compared to the overall cohort (40 vs. 60 %, P < 0.001). The mean time to symptom onset was 31 days. The Tb, ALT, and ALP were 7 mg/dL, 478, and 325 U/L at onset. Nearly all liver biopsies showed prominent cholestatic features. Resolution of AC-DILI, defined by return of Tb to <2.5 mg/dL, occurred on average 55 days after the peak value. Three female subjects required liver transplantation, and none died due to DILI. CONCLUSION: AC-DILI causes a moderately severe, mixed hepatocellular-cholestatic injury, particularly in older men, unlike DILI in general, which predominates in women. Although often protracted, eventual apparent recovery is typical, particularly for men and usually in women, but three women required liver transplantation.
BACKGROUND AND AIMS: Amoxicillin-clavulanate (AC) is the most frequent cause of idiosyncratic drug-induced injury (DILI) in the US DILI Network (DILIN) registry. Here, we examined a large cohort of AC-DILI cases and compared features of AC-DILI to those of other drugs. METHODS: Subjects with suspected DILI were enrolled prospectively, and cases were adjudicated as previously described. Clinical variables and outcomes of patients with AC-DILI were compared to the overall DILIN cohort and to DILI caused by other antimicrobials. RESULTS: One hundred and seventeen subjects with AC-DILI were identified from the cohort (n = 1038) representing 11 % of all cases and 24 % of those due to antimicrobial agents (n = 479). Those with AC-DILI were older (60 vs. 48 years, P < 0.001). AC-DILI was more frequent in men than women (62 vs. 39 %) compared to the overall cohort (40 vs. 60 %, P < 0.001). The mean time to symptom onset was 31 days. The Tb, ALT, and ALP were 7 mg/dL, 478, and 325 U/L at onset. Nearly all liver biopsies showed prominent cholestatic features. Resolution of AC-DILI, defined by return of Tb to <2.5 mg/dL, occurred on average 55 days after the peak value. Three female subjects required liver transplantation, and none died due to DILI. CONCLUSION:AC-DILI causes a moderately severe, mixed hepatocellular-cholestatic injury, particularly in older men, unlike DILI in general, which predominates in women. Although often protracted, eventual apparent recovery is typical, particularly for men and usually in women, but three women required liver transplantation.
Authors: M Isabel Lucena; Mariam Molokhia; Yufeng Shen; Thomas J Urban; Guruprasad P Aithal; Raúl J Andrade; Christopher P Day; Francisco Ruiz-Cabello; Peter T Donaldson; Camilla Stephens; Munir Pirmohamed; Manuel Romero-Gomez; Jose Maria Navarro; Robert J Fontana; Michael Miller; Max Groome; Emmanuelle Bondon-Guitton; Anita Conforti; Bruno H C Stricker; Alfonso Carvajal; Luisa Ibanez; Qun-Ying Yue; Michel Eichelbaum; Aris Floratos; Itsik Pe'er; Mark J Daly; David B Goldstein; John F Dillon; Matthew R Nelson; Paul B Watkins; Ann K Daly Journal: Gastroenterology Date: 2011-04-12 Impact factor: 22.682
Authors: M L Hautekeete; Y Horsmans; C Van Waeyenberge; C Demanet; J Henrion; L Verbist; R Brenard; C Sempoux; P P Michielsen; P S Yap; J Rahier; A P Geubel Journal: Gastroenterology Date: 1999-11 Impact factor: 22.682
Authors: M Isabel Lucena; Raúl J Andrade; M Carmen Fernández; Ketevan Pachkoria; Gloria Pelaez; José A Durán; Macarena Villar; Luis Rodrigo; Manuel Romero-Gomez; Ramón Planas; Anabel Barriocanal; Joan Costa; Carlos Guarner; Sonia Blanco; José M Navarro; Fernando Pons; Agustin Castiella; Susana Avila Journal: Hepatology Date: 2006-10 Impact factor: 17.425
Authors: Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi Journal: Hepatology Date: 2010-06 Impact factor: 17.425
Authors: Thomas J Urban; Yufeng Shen; Andrew Stolz; Naga Chalasani; Robert J Fontana; James Rochon; Dongliang Ge; Kevin V Shianna; Ann K Daly; M Isabel Lucena; Matthew R Nelson; Mariam Molokhia; Guruprasad P Aithal; Aris Floratos; Itsik Pe'er; Jose Serrano; Herbert Bonkovsky; Timothy J Davern; William M Lee; Victor J Navarro; Jayant A Talwalkar; David B Goldstein; Paul B Watkins Journal: Pharmacogenet Genomics Date: 2012-11 Impact factor: 2.089
Authors: Melina M Malinen; Izna Ali; Jacqueline Bezençon; James J Beaudoin; Kim L R Brouwer Journal: Am J Physiol Gastrointest Liver Physiol Date: 2018-02-08 Impact factor: 4.052
Authors: Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle Journal: Hepatology Date: 2017-02-07 Impact factor: 17.425
Authors: Frank DiPaola; Jean P Molleston; Jiezhun Gu; Elizabeth T Cirulli; Naga Chalasani; Huiman Barnhart; David E Kleiner; Jay H Hoofnagle; Robert J Fontana Journal: J Pediatr Gastroenterol Nutr Date: 2019-08 Impact factor: 2.839
Authors: Jessica Whritenour; Mira Ko; Qing Zong; Jianying Wang; Karrie Tartaro; Patricia Schneider; Ellen Olson; Maria Van Volkenburg; Jose Serrano; Paul Hayashi; Robert Fontana; Naga Chalasani; Herbert L Bonkovsky Journal: J Immunotoxicol Date: 2017-12 Impact factor: 3.000
Authors: Elizabeth T Cirulli; Paola Nicoletti; Karen Abramson; Raul J Andrade; Einar S Bjornsson; Naga Chalasani; Robert J Fontana; Pär Hallberg; Yi Ju Li; M Isabel Lucena; Nanye Long; Mariam Molokhia; Matthew R Nelson; Joseph A Odin; Munir Pirmohamed; Thorunn Rafnar; Jose Serrano; Kári Stefánsson; Andrew Stolz; Ann K Daly; Guruprasad P Aithal; Paul B Watkins Journal: Gastroenterology Date: 2019-01-18 Impact factor: 22.682